Edition:
India

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

998JPY
10:33am IST
Change (% chg)

¥44 (+4.61%)
Prev Close
¥954
Open
¥965
Day's High
¥1,054
Day's Low
¥935
Volume
9,560,500
Avg. Vol
795,203
52-wk High
¥1,054
52-wk Low
¥618

Select another date:

Wed, Jan 17 2018

BRIEF-NanoCarrier starts to discuss business alliance with Ceolia Pharma

* Says it starts to discuss business alliance with Ceolia Pharma Co., Ltd., and will cooperate on sale, manufacture and development of pharmaceuticals

BRIEF-NanoCarrier signs license preferential negotiating rights agreement with AccuRna

* Says it and AccuRna Inc entered into a preferential negotiating rights agreement on exclusive right to license of drug development based on co's gene delivery technology

BRIEF-VBL Therapeutics and Nanocarrier signs agreement for VB-111 in Japan

* VBL Therapeutics and Nanocarrier Co Ltd sign exclusive agreement for VB-111 in Japan

BRIEF-Nanocarrier signs exclusive agreement with VBL Therapeutics for VB-111 in Japan

* Says co signs an exclusive license agreement with VBL Therapeutics, for the development, commercialization, and supply of ofranergene obadenovec ("VB-111") in Japan

BRIEF-NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines

* Says it and NanoCarrier Co., Ltd conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines

BRIEF-NanoCarrier says orphan drug designation of NC-6004 by the U.S. FDA

* Says NC-6004, which is under development in the U.S. for biliary cancer, has been granted to the orphan drug designation from the U.S. FDA (Food and Drug Administration)

Select another date: